Ebola

Ebola virus disease is a highly contagious infectious condition caused by distinct species within the ebolavirus genus ^[1][2]. The clinical pathology is characterized by rapid systemic deterioration, encompassing gastrointestinal failure, hepatic and renal impairment, and profound coagulopathy ^[5][2]. Accurate identification depends on established diagnostic criteria paired with molecular or antigen-based laboratory confirmation ^[5].

Initial manifestations typically emerge two to twenty-one days post-exposure and feature abrupt fever, profound fatigue, myalgia, cephalgia, and pharyngitis ^[1][2]. Disease progression commonly introduces emesis, diarrhoea, cutaneous eruptions, and visceral dysfunction, frequently accompanied by impaired hemostasis ^[1][2]. Hemorrhagic phenomena, including mucosal oozing, gastrointestinal bleeding, and injection site hematoma, generally appear five to seven days after symptom initiation and affect approximately half of confirmed cases ^[2]. Without timely physiological stabilization, patients frequently succumb to hypovolemic shock within a fortnight of onset ^[2].

Historical emergence dates to simultaneous 1976 incidents in Sudan and the Democratic Republic of Congo, establishing a pattern of sporadic regional outbreaks ^[3][1]. Endemic activity predominantly concentrates in remote Central African settlements adjacent to tropical forest ecosystems, though recent decades demonstrate expanded geographic reach ^[1]. The unprecedented 2013–2016 West African epidemic overwhelmed national health systems, generating nearly thirty thousand infections and exceeding eleven thousand deaths while crossing international boundaries ^[4]. Ongoing surveillance continues to document localized resurgence in Central African territories, underscoring persistent ecological reservoirs and transmission vulnerabilities ^[3][2].

Primary spillover events originate from direct interaction with asymptomatic wildlife carriers, notably Pteropodidae fruit bats and other forest-dwelling mammals ^[1][2]. Sustained human propagation occurs exclusively through intimate contact with fresh blood, secretions, excretions, or solid organs of symptomatic individuals, as well as through environmental surfaces recently saturated with these fluids ^[1][2]. Fomite-mediated pathways remain viable until viral degradation occurs, while respiratory droplet or aerosol dissemination between humans lacks empirical documentation ^[2]. Infectivity commences only upon clinical symptom onset and may persist in reproductive fluids or breast milk for several months following convalescence ^[1][2].

Community-level mitigation centers on eliminating direct exposure to suspected animal reservoirs and rigorously applying barrier precautions when managing patient secretions or contaminated medical equipment ^[2]. Public health authorities deploy ring vaccination protocols targeting identified patient contacts and frontline responders to establish immunological buffers around active transmission clusters ^[4]. Enhanced diagnostic capacity and standardized isolation procedures further restrict nosocomial amplification during acute care episodes ^[5]. Continuous environmental decontamination and safe burial practices remain essential components of comprehensive outbreak containment frameworks ^[3].

1. 1World Health Organization. Ebola global [Internet]. cited 3 Sept 2026.Available from: https://www.who.int/health-topics/ebola
2. 2Wikipedia contributors. Ebola - Wikipedia [Internet]. Wikipedia. cited 3 Sept 2026.Available from: https://en.wikipedia.org/wiki/Ebola
3. 3Letafati A et al. Ebola virus disease: A narrative review. Microb Pathog. 2023 Aug. PMID: 37355146. doi: 10.1016/j.micpath.2023.106213.PubMed: https://pubmed.ncbi.nlm.nih.gov/37355146/
4. 4Furuyama W et al. Ebola Virus: Pathogenesis and Countermeasure Development. Annu Rev Virol. 2019 Sep 29. PMID: 31567063. doi: 10.1146/annurev-virology-092818-015708.PubMed: https://pubmed.ncbi.nlm.nih.gov/31567063/
5. 5Jacob ST et al. Ebola virus disease. Nat Rev Dis Primers. 2020 Feb 20. PMID: 32080199. doi: 10.1038/s41572-020-0147-3.PubMed: https://pubmed.ncbi.nlm.nih.gov/32080199/